Publisher
Springer International Publishing
Reference15 articles.
1. Agaram, N. P., Zhang, L., Sung, Y. S., Singer, S., & Antonescu, C. R. (2014). Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology. Human Pathology, 45(5), 1084–1091.
2. Attwooll, C., Tariq, M., Harris, M., Coyne, J. D., Telford, N., & Varley, J. M. (1999). Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene, 18(52), 7599–7601.
3. Brenca, M., Stacchiotti, S., Fassetta, K., et al. (2019). NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas. The Journal of Pathology, 249(1), 90–101.
4. Clark, J., Benjamin, H., Gill, S., et al. (1996). Fusion of the EWS gene to CHN, a member of the steroid thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene, 12, 229–235.
5. Finos, L., Righi, A., Frisoni, T., et al. (2017). Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature. Pathology, Research and Practice, 213(5), 461–466.